tiprankstipranks
Advertisement
Advertisement

ALT Stock Latest News

3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
Market News3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
1d ago
ALT
KDK
Altimmune Charts Long Runway with Bold Trial Push
PremiumCompany Announcements
Altimmune Charts Long Runway with Bold Trial Push
10d ago
ALT
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
PremiumRatings
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
17d ago
ALT
Altimmune reports Q2 EPS (12c), consensus (12c)
PremiumThe Fly
Altimmune reports Q2 EPS (12c), consensus (12c)
17d ago
ALT
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
PremiumWeekend Updates
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
18d ago
ALT
ETN
Is ALT a Buy, Before Earnings?
PremiumPre-EarningsIs ALT a Buy, Before Earnings?
24d ago
ALT
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
30d ago
ALT
Altimmune initiates PERFORMA trial
Premium
The Fly
Altimmune initiates PERFORMA trial
1M ago
ALT
Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
PremiumCompany Announcements
Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
1M ago
ALT
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
PremiumThe Fly
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
1M ago
ALT
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
PremiumThe Fly
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
1M ago
ALT
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
PremiumThe Fly
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
1M ago
ALT
Unusually active option classes on open July 28th
PremiumThe FlyUnusually active option classes on open July 28th
1M ago
ALT
HTZ
Altimmune Reports Positive Phase 2 Data in AUD
Premium
Company Announcements
Altimmune Reports Positive Phase 2 Data in AUD
1M ago
8K
ALT
Altimmune announces RECLAIM trial met primary endpoint
Premium
The Fly
Altimmune announces RECLAIM trial met primary endpoint
1M ago
ALT
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
PremiumWeekend Updates
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
2M ago
ALT
GPN
Unusually active option classes on open June 24th
PremiumThe Fly
Unusually active option classes on open June 24th
2M ago
BP
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
2M ago
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
2M ago
ALT
Altimmune Relocates Corporate Headquarters to Morristown, New Jersey
PremiumCompany AnnouncementsAltimmune Relocates Corporate Headquarters to Morristown, New Jersey
3M ago
8K
ALT
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
Premium
The Fly
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
3M ago
ALT
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
Premium
The Fly
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
4M ago
ALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >